Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioTime Inc (NYSE American:BTX)

2.80
Delayed Data
As of Sep 22
 +0.01 / +0.36%
Today’s Change
2.47
Today|||52-Week Range
4.01
-22.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues4.4M5.2M7.0M5.9M
 
 
 
 
 
Cost of Goods Sold792.7K837.1K1.1M358.0K
 
 
 
 
 
Depreciation And Amortization4.0M8.4M6.3M4.8M
 
 
 
 
 
 
Operating ExpensesGross Income-310.8K-4.0M-405.0K808.0K
 
 
 
 
 
General Expenses38.2M46.7M65.4M59.8M
 
 
 
 
 
Research And Development23.3M30.2M37.3M32.5M
 
 
 
 
 
Total Operating Expenses43.0M55.9M72.8M64.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.5M-50.7M-65.8M-59.0M
 
 
 
 
 
Extraordinary Charge-17.5M0.000.000.00
 
 
Pre-Tax Equity Earnings-----35.0K29.7M
 
 
 
Interest Expense On Debt--91.0K465.0K747.0K
 
 
 
 
Other Expenses-207.1K-383.6K3.5M48.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-56.2M-51.2M-62.7M18.6M
 
 
 
 
 
Income Taxes-3.3M-7.4M-4.5M0.00
 
 
 
 
Minority Interest-9.0M-7.4M-11.1M-15.0M
 
 
 
 
 
Preferred Dividend0.00-86.8K-415.0K0.00
 
 
 
Net Income-43.9M-36.4M-47.0M33.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS54.2M66.5M79.7M97.3M
 
 
 
 
 
Shares To Calculate EPS Diluted54.2M66.5M79.7M99.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.81-$0.55-$0.59$0.34
 
 
 
 
 
EPS Diluted-$0.81-$0.55-$0.59$0.34